FMI
CORT icon

F/M Investments’s Corcept Therapeutics CORT Stock Holding History

F/M Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.66M Buy
88,042
+36,890
+72% +$2.23M 0.39% 57
2026
Q1 		$2.06M Sell
51,152
-14,742
-22% -$551K 0.14% 105
2025
Q4 		$2.29M Buy
65,894
+36,207
+122% +$2.84M 0.09% 220
2025
Q3 		$2.47M Buy
29,687
+7,714
+35% +$558K 0.1% 214
2025
Q2 		$1.61M Buy
+21,973
New +$1.59M 0.06% 261

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

F/M Investments's CORT Position: Q2 2026 in Review

F/M Investments increased its Corcept Therapeutics (CORT) stake by 72% in Q2 2026, buying an estimated $2.23M and bringing the position to 88,042 shares worth $7.66M. The position accounts for 0.39% of the portfolio, ranked #57.

F/M Investments first reported a position in CORT in Q2 2025 and has held it in 5 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • F/M Investments held 88,042 shares of Corcept Therapeutics worth $7.66M as of Q2 2026.
  • F/M Investments bought 36,890 Corcept Therapeutics shares in Q2 2026, an estimated $2.23M.
  • Corcept Therapeutics made up 0.39% of F/M Investments's portfolio in Q2 2026, its #57 holding.
  • F/M Investments first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.